UNITED THERAPEUTICS CORP
UTHRNASDAQ🏆 #429 by market capEarnings Oct 27 · PreUS Equity
$950.02▲ $43.32 (+4.56%)
Simulated price1h—
24h▲ 4.6%
7d—
14d—
30d—
1y—
🏦Market Cap
$23.11B
Mid Cap
📈Revenue Growth (YoY)
+2.5%
Slowing
📊Gross Margin
86.1%
High
💵FCF Margin
34.5%
Strong
⚖️P/S Ratio
7.3x
Fair
Otter Score
59
Weak
No chart data available for UTHR.
Trading Snapshot
- Day Range
- $942.66 – $960.04
- 52-Week Range
- $292.34 – $609.35
- Volume
- $2.13B
- Avg Volume
- $2.24B
- Shares Outstanding
- 42.5M
- Next Earnings
- Sep 23, 2026
Fundamentals Snapshot
- Annual Revenue
- $3.15B
- Last Q Revenue
- $780M
- P/E Ratio
- 17.6
- P/S Ratio
- 7.3x
- EPS (TTM)
- $27.96
- Dividend Yield
- —
Why Investors Own UTHR
- ✓High-growth profile — revenue up -8.7% YoY with expanding US Equity exposure.
- ✓Healthy economics — 28% gross margin and 25% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$3.15B▼ −12.7% YoY
Gross Margin (TTM)
28.1%▲ +1.2% YoY
Operating Income (TTM)
$722M▼ −12.7% YoY
Free Cash Flow (TTM)
$789M▼ −12.7% YoY
About UNITED THERAPEUTICS CORP
A company profile for UNITED THERAPEUTICS CORP isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
59/100
Analyst Price Target
ⓘAverage Target
$974.63
▲ +2.6% Upside
High Target$1,153.01
Low Target$838.86
Based on 14 analysts
Latest News & Updates
🚀
MarketWatch·2h ago
UNITED THERAPEUTICS CORP tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Bloomberg·5h ago
Analysts lift UTHR price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
MarketWatch·1d ago
UNITED THERAPEUTICS CORP announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.